World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders.
Hubertus HimmerichYael Doreen LewisChiara ContiHiba MutwalliAndreas F K KarwautzJan Magnus SjögrenMaría Mercedes Uribe IsazaMarta Tyszkiewicz-NwaforMartin AignerSusan L McElroyJanet TreasureSiegfried Kaspernull nullPublished in: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry (2023)
In BN, fluoxetine, and topiramate, and in BED, LDX and topiramate can be recommended. Despite the published evidence, olanzapine and topiramate have not received marketing authorisation for use in EDs from any medicine regulatory agency.